Key points are not available for this paper at this time.
A set of principles are outlined for the design of short oligopeptides which will self-assemble in appropriate solvents into long, semi-flexible, polymericβ-sheet nanotapes. Their validity is demonstrated by experimental studies of an 11-residue peptide (DN1) which forms nanotapes in water, and a 24-residue peptide (K24) which forms nanotapes in non-aqueous solvents such as methanol. Circular dichroism (CD) spectroscopy studies of the self-assembly behaviour in very dilute solutions (µm) reveal a simple transition from a random coil-to-β-sheet conformation in the case of DN1, but a more complex situation for K24. Association of DN1 is very weak up to a concentration of 40 µm at which there is a sudden increase in the fraction of peptide in the β-sheet structure, indicative of an apparent ‘critical tape concentration’. This is shown to arise from a two-step self-assembly process: the first step being a transition from a random coil to an extended β-strand conformation, and the second the addition of this β-strand to a growing β-sheet. Both peptides are shown to gel their solvents at concentrations above 2×10 -3 volume fraction: these gels are stable up to the boiling point of the solvents. Rheology measurements on gels of the 24-residue peptide in 2-chloroethanol reveal that the tapes form an entangled network with a mesh size of 10–100 nm for peptide volume fractions 0.03–0.003; the persistence length of the tape is 13 nm or greater, indicative of a moderately rigid polymer; the tapes are about a single molecule in thickness. The mechanical properties of the gels in many respects are comparable to those of natural biopolymers such as gelatin, actin, amylose and agarose.
Aggeli et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: